10Jan 2025
GLP-1 Agonists: Effective for Obesity Management

GLP-1 Agonists: Effective for Obesity Management

A review of 26 RCTs involving 15,491 participants assessed GLP-1 receptor agonists and co-agonists for obesity management in adults without diabetes. Tirzepatide (15 mg weekly) achieved up to 17.8% weight loss, semaglutide (2.4 mg weekly) up to 13.9%, and liraglutide (3.0 mg daily) up to 5.8%. Retatrutide showed the highest weight loss at 22.1%. Gastrointestinal adverse events were common, but severe adverse events were rare.

  • #family health
  • #pharmacology

Like

Save

Share